BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31413608)

  • 1. Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis.
    Migliore A; Integlia D; Pompilio G; Di Giuseppe F; Aru C; Brown T
    Clinicoecon Outcomes Res; 2019; 11():453-464. PubMed ID: 31413608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia.
    Castro JC; Daza AM; Misas JD
    Value Health Reg Issues; 2015 Dec; 8():56-61. PubMed ID: 29698172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
    Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
    Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
    Adams ME; Atkinson MH; Lussier AJ; Schulz JI; Siminovitch KA; Wade JP; Zummer M
    Osteoarthritis Cartilage; 1995 Dec; 3(4):213-25. PubMed ID: 8689457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
    Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
    Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.
    Migliore A; Giovannangeli F; Granata M; Laganà B
    Clin Med Insights Arthritis Musculoskelet Disord; 2010 Sep; 3():55-68. PubMed ID: 21151854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscosupplementation for the treatment of osteoarthritis of the knee.
    Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
    Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005321. PubMed ID: 16625635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Comparative Analysis of Opioid Use and Intra-Articular Corticosteroid Injections Before and After Initial Treatment of Knee Osteoarthritis with Hylan G-F 20.
    Khangulov V; Zhang X; Munson SH; Peyerl F; Rey F
    Open Access Rheumatol; 2020; 12():79-85. PubMed ID: 32581606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscosupplementation for the treatment of osteoarthritis of the knee.
    Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005321. PubMed ID: 15846754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study.
    Khanasuk Y; Dechmaneenin T; Tanavalee A
    J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S92-7. PubMed ID: 23451445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.
    Torrance GW; Raynauld JP; Walker V; Goldsmith CH; Bellamy N; Band PA; Schultz M; Tugwell P;
    Osteoarthritis Cartilage; 2002 Jul; 10(7):518-27. PubMed ID: 12127831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial.
    Wang Y; Hall S; Hanna F; Wluka AE; Grant G; Marks P; Feletar M; Cicuttini FM
    BMC Musculoskelet Disord; 2011 Aug; 12():195. PubMed ID: 21861935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up.
    Migliore A; Tormenta S; Martin Martin LS; Iannessi F; Massafra U; Carloni E; Monno D; Alimonti A; Granata M
    Clin Rheumatol; 2006 May; 25(3):389-93. PubMed ID: 16249827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.
    Migliore A; Tormenta S; Massafra U; Bizzi E; Iannessi F; Alimonti A; Granata M
    Curr Med Res Opin; 2008 May; 24(5):1309-16. PubMed ID: 18373891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
    Waddell DD; Bricker DC
    J Manag Care Pharm; 2007 Mar; 13(2):113-121. PubMed ID: 17330972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Knee Arthroplasty in a Knee Osteoarthritis Patient Cohort Treated with Intra-articular Injections of Hylan G-F 20.
    Ong K; Lau E; Runa M; Daley W; Altman R
    J Knee Surg; 2021 Jul; 34(8):886-897. PubMed ID: 31874465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.